Autosomal Recessive Spastic Paraplegia Type 39

Watchlist
Retrieved
2021-01-23
Source
Trials
Genes
Drugs

This syndrome is characterised by progressive spastic paraplegia and distal muscle wasting.

Epidemiology

So far, it has been described in two families.

Etiology

All affected individuals carried mutations in the neuropathy target esterase (NTE) gene, encoding a neural membrane protein.